New research shows that moderate coffee consumption may reduce risk of having two or more cardio or metabolic diseases at the same time.
The study, published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism in September, follows numerous studies suggesting that coffee may have protective effects against individual cardiometabolic diseases, such as type 2 diabetes, coronary heart disease and stroke.
This study showed pronounced protective effects against the simultaneous existence of two or more cardiometabolic diseases. Study participants who drank approximately three cups of coffee per day were 48.1% less likely to develop multiple cardiometabolic diseases — known as “cardiometabolic multimorbidity” (CM) — than non coffee drinkers.
Led by researchers in China, the study drew data from the UK Biobank, which has provided a wealth of health-related data for coffee researchers and includes more than 500,000 participants.
“Habitual coffee or caffeine intake, especially at a moderate level, was associated with a lower risk of new-onset CM and could play important roles in almost all transition phases of CM development,” the authors concluded. “Future studies are warranted to validate the implicated metabolic biomarkers underlying the relation between coffee, tea, and caffeine intake and CM.”
The full study is available here.
Comments? Questions? News to share? Contact DCN’s editors here.
Related Posts
Comment